Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

BMS 193885

Known as: BMS-193885, BMS193885 
 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

DihydropyridinesPhenylurea Compounds

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Radiosynthesis and in vivo evaluation of 11C-labeled BMS-193885 and its desmethyl analog as PET tracers for neuropeptide Y1 receptors
BackgroundNeuropeptide Y (NPY) has been implicated in a wide variety of physiological processes, including feeding, learning… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
2018
Highly Cited
2018
Structural basis of ligand binding modes at the neuropeptide Y Y1 receptor
Neuropeptide Y (NPY) receptors belong to the G-protein-coupled receptor superfamily and have important roles in food intake… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2018
2018
Orexin-A signaling in the paraventricular nucleus modulates spontaneous firing of glucose-sensitive neurons and promotes food intake via the NPY pathway in rats.
Understanding the mechanisms regulating feeding is crucial to unraveling the pathogenesis of obesity. The study primary explored… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2008
2008
Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.
Treatment of obesity is still a large unmet medical need. Neuropeptide Y is the most potent orexigenic peptide in the animal… Expand
2004
2004
Dihydropyridine neuropeptide Y Y1 receptor antagonists 2. bioisosteric urea replacements.
Structure-activity studies around the urea linkage in BMS-193885 (4a) identified the cyanoguanidine moiety as an effective urea… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE